Literature DB >> 32348916

Cardiolipin remodeling in Barth syndrome and other hereditary cardiomyopathies.

Edoardo Bertero1, Ilona Kutschka1, Christoph Maack1, Jan Dudek2.   

Abstract

Mitochondria play a prominent role in cardiac energy metabolism, and their function is critically dependent on the integrity of mitochondrial membranes. Disorders characterized by mitochondrial dysfunction are commonly associated with cardiac disease. The mitochondrial phospholipid cardiolipin directly interacts with a number of essential protein complexes in the mitochondrial membranes including the respiratory chain, mitochondrial metabolite carriers, and proteins critical for mitochondrial morphology. Barth syndrome is an X-linked disorder caused by an inherited defect in the biogenesis of the mitochondrial phospholipid cardiolipin. How cardiolipin deficiency impacts on mitochondrial function and how mitochondrial dysfunction causes cardiomyopathy has been intensively studied in cellular and animal models of Barth syndrome. These findings may also have implications for the molecular mechanisms underlying other inherited disorders associated with defects in cardiolipin, such as Sengers syndrome and dilated cardiomyopathy with ataxia (DCMA).
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Barth syndrome; Cardiolipin; Dilated cardiomyopathy with ataxia; Mitochondria; Mitochondriopathies; Respiratory chain; Sengers syndrome

Mesh:

Substances:

Year:  2020        PMID: 32348916     DOI: 10.1016/j.bbadis.2020.165803

Source DB:  PubMed          Journal:  Biochim Biophys Acta Mol Basis Dis        ISSN: 0925-4439            Impact factor:   5.187


  6 in total

Review 1.  Mechanisms of mitochondrial respiratory adaptation.

Authors:  Christopher F Bennett; Pedro Latorre-Muro; Pere Puigserver
Journal:  Nat Rev Mol Cell Biol       Date:  2022-07-08       Impact factor: 94.444

2.  ost in promiscuity? An evolutionary and biochemical evaluation of HSD10 function in cardiolipin metabolism.

Authors:  Yvonne Wohlfarter; Reiner Eidelpes; Ryan D Yu; Sabrina Sailer; Jakob Koch; Daniela Karall; Sabine Scholl-Bürgi; Albert Amberger; Hauke S Hillen; Johannes Zschocke; Markus A Keller
Journal:  Cell Mol Life Sci       Date:  2022-10-22       Impact factor: 9.207

Review 3.  Cardiolipin, Mitochondria, and Neurological Disease.

Authors:  Micol Falabella; Hilary J Vernon; Michael G Hanna; Steven M Claypool; Robert D S Pitceathly
Journal:  Trends Endocrinol Metab       Date:  2021-02-24       Impact factor: 12.015

Review 4.  Cardiomyopathies in Children and Systemic Disorders When Is It Useful to Look beyond the Heart?

Authors:  Valentina Lodato; Giovanni Parlapiano; Federica Calì; Massimo Stefano Silvetti; Rachele Adorisio; Michela Armando; May El Hachem; Antonino Romanzo; Carlo Dionisi-Vici; Maria Cristina Digilio; Antonio Novelli; Fabrizio Drago; Massimiliano Raponi; Anwar Baban
Journal:  J Cardiovasc Dev Dis       Date:  2022-01-31

5.  Novel homozygous pathogenic mitochondrial DNAJC19 variant in a patient with dilated cardiomyopathy and global developmental delay.

Authors:  Abeer Al Tuwaijri; Yusra Alyafee; Mashael Alharbi; Maryam Ballow; Mohammed Aldrees; Qamre Alam; Rola A Sleiman; Muhammad Umair; Majid Alfadhel
Journal:  Mol Genet Genomic Med       Date:  2022-05-25       Impact factor: 2.473

Review 6.  Reactive Oxygen Species Induced Pathways in Heart Failure Pathogenesis and Potential Therapeutic Strategies.

Authors:  Aušra Mongirdienė; Laurynas Skrodenis; Leila Varoneckaitė; Gerda Mierkytė; Justinas Gerulis
Journal:  Biomedicines       Date:  2022-03-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.